ClinicalTrials.gg
Not yet recruitingNCT06998914Updated May 31, 2025

Arthroscopic Assisted Distal Radius Fracture Fixation

An observational study in Radius Fracture, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-05-31.

Sponsored by Assiut University · Observational

From the registry’s dates

  • Primary completion was expected by May 2026, 5 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
20
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Distal radius fractures (DRF) are among the most common orthopedic injuries, both in young adults and in elderly patients.(1,2,4،7 ) Effective management of these fractures is crucial to restoring wrist function, ensuring stability, and minimizing complications. (2)Traditional open reduction and internal fixation (ORIF) remains the cornerstone of treatment. (3)However, minimally invasive techniques are increasingly gaining attention for their ability to improve outcomes while reducing complications.(5, 8) Wrist arthroscopy has emerged as a valuable tool in the management of DRF. It allows for direct visualization of intra-articular fractures, assessment of associated soft tissue injuries, and precise reduction of fracture fragments. Additionally, it facilitates the identification and management of concomitant injuries, such as triangular fibrocartilage complex (TFCC) tears or ligament injuries, which are frequently overlooked in traditional techniques. (6, 9 ،10) Despite these advantages, the use of wrist arthroscopy in DRF management remains underutilized in many regions. In Assiut University Hospital, there is a growing interest in incorporating advanced techniques, including wrist arthroscopy, into the management of orthopedic injuries. However, there is limited local data on the outcomes and feasibility of this approach in the treatment of DRF. This case series aims to evaluate the clinical and functional outcomes of DRF management using wrist arthroscopy, providing insight into its effectiveness, safety, and applicability in a tertiary care setting. By documenting the experiences and outcomes of patients treated with this innovative technique, this study seeks to contribute to the existing literature and guide the future adoption of arthroscopy-assisted methods in DRF management in the region.

-The aim of this study is to evaluate the clinical and functional outcomes of managing distal radius fractures assisted by wrist arthroscopy at Assiut University Hospital using Mayo wrist score, with a focus on its effectiveness, safety, and feasibility in improving fracture reduction, identifying associated injuries, and enhancing patient recovery.

02

Conditions studied

  • Radius Fracture

Browse trials for

03

In context

Radius Fractures

274 studies on the registry are indexed under Radius Fractures; 35 are open to participants now.

This study's planned enrollment of 20 is below the median of 60 across 46 observational studies indexed under Radius Fractures.

Browse Radius Fractures studies →

Lead sponsor

Assiut University is the lead sponsor of 5,050 studies on the registry; 2,174 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Recent distal radius fractures which occurred less than 14 day clssification 2R3B1,2R3B2,2R3B3,2R3C1 on AO classification with articular surface displacement or gap ≥ 2mm after reduction

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Recent distal radius fractures which occurred less than 14 day clssification 2R3B1,2R3B2,2R3B3,2R3C1 on AO classification with articular surface displacement or gap ≥ 2mm after reduction
  • Patient aged from 18 to 60 years.
  • Potential associated ligament injuries.

Exclusion criteria

Exclusion Criteria:

  • Poly-traumatized patients or those with other fractures in the same upper limb.
  • Open fractures or neurovascular deficit or medical fractures.
  • Patient with severe complications that prevent clear visualization during arthroscopy.
  • Patient with uncontrolled chronic diseases, especially uncontrolled DM or HTN
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
20 participants (estimated)
Patient registry
No

Groups and cohorts

  • study group

    Recent distal radius fractures which occurred less than 14 day clssification 2R3B1,2R3B2,2R3B3,2R3C1 on AO classification with articular surface displacement or gap ≥ 2mm after reduction

06

What researchers measure

Primary outcomes

  1. healing of radius fracture

    evaluate distal radius fracture treated by wrist arthroscopy using The X-ray beam was centered 1 m above the radius fracture. Anteroposterior (AP) and lateral films (LAT) were taken Four orthopedic surgeons with similar ranks were chosen and blindly asked to evaluate three parameters of radiographic measurements for each set of radiographs.

    Time frame: 6 month

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2025; primary completion for May 2026, 9 months later.

Of 15 observational studies under Radius Fractures, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 25. This study's planned 9 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 14, 2025
First posted
May 31, 2025
StartEst.
Aug 1, 2025
Primary completionEst.
May 1, 2026
CompletionEst.
Nov 1, 2026
Last update
May 31, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06998914
Lead sponsor
Assiut University
Responsible party
Mostafa Ahmed Mansour Mohamed (residant doctor, Assiut University) — Principal investigator
First posted
May 31, 2025
Start date
Aug 1, 2025 (estimated)
Primary completion
May 1, 2026 (estimated)
Completion
Nov 1, 2026 (estimated)
Last update
May 31, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion